Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma
  1. Home
  2. Publications
  3. Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma

Supplementary Table 2 from RALDH1 Inhibition Shows Immunotherapeutic Efficacy in Hepatocellular Carcinoma

Authors:
  • PYPengfei Yu
    Pengfei Yu
  • SCShuwen Cao
    Shuwen Cao
  • SYShyh-Ming Yang
    Shyh-Ming Yang
  • GRGanesha Rai
    Ganesha Rai
  • NMNatalia J. Martinez
    Natalia J. Martinez
  • AYAdam Yasgar
    Adam Yasgar
  • AZAlexey V. Zakharov
    Alexey V. Zakharov
  • ASAnton Simeonov
    Anton Simeonov
  • WAWilliam A. Molina Arocho
    William A. Molina Arocho
  • GLGraham P. Lobel
    Graham P. Lobel
  • HMHesham Mohei
    Hesham Mohei
  • ASAlexis L. Scott
    Alexis L. Scott

Open Access
Publisher website
Google Scholar
  • 2 February 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.25132681.v1
Abstract
Table comparing various key pharmacokinetic parameters (Assay, left column) between C-91 and C-86.
Keywords
  • GASTROINTESTINAL CANCERS
  • LIVER CANCER
  • IMMUNOTHERAPY
  • TUMOR MICROENVIRONMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.